Blackhawk Capital Partners Llc. Novartis Ag Transaction History

Blackhawk Capital Partners Llc.

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 11, 2021	SELL	$83.5 - $98.47 $283,816 - $334,699	-3,399 Closed	0 $0
Q4 2020 Feb 10, 2021	BUY	$78.07 - $94.43 $10,461 - $12,653	134 Added 4.1%	3,399 $296,000
Q3 2020 Nov 16, 2020	SELL	$82.14 - $91.0 $152,780 - $169,260	-1,860 Reduced 36.29%	3,265 $285,000
Q2 2020 Aug 04, 2020	BUY	$80.93 - $91.1 $414,766 - $466,887	5,125 New	5,125 $423,000
Q2 2019 Aug 13, 2019	SELL	$75.4 - $92.8 $186,765 - $229,865	-2,477 Closed	0 $0
Q1 2019 May 08, 2019	SELL	$75.32 - $86.15 $57,770 - $66,077	-767 Reduced 23.64%	2,477 $238,000
Q4 2018 Feb 04, 2019	BUY	$73.66 - $82.02 $238,953 - $266,072	3,244 New	3,244 $278,000
Q3 2018 Nov 13, 2018	SELL	$66.94 - $77.43 $133,545 - $154,472	-1,995 Closed	0 $0
Q1 2018 May 15, 2018	SELL	$70.39 - $84.15 $15,837 - $18,933	-225 Reduced 10.14%	1,995 $161,000
Q4 2017 Feb 12, 2018	BUY	$72.33 - $77.64 $160,572 - $172,360	2,220	2,220 $186,000

1,439

135M

1.12M

1.82M

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $229B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

Get notified when there are updates to the investment portfolio of Blackhawk Capital Partners Llc., based on Form 13F filings with the SEC.

Stay updated on Blackhawk Capital Partners Llc. with notifications on news.